Moleculin Biotech, Inc. Tax Withholding Paid on Stock Awards
Moleculin Biotech, Inc. (MBRX) reported Tax Withholding Paid on Stock Awards of $8.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-03-18
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $8.00K.
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-12-31 was $0.00.
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-09-30 was $1.00K, a 75.00% decline year-over-year.
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $8.00K, a 69.23% decline from fiscal 2024.
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $26.00K, a 4.00% increase from fiscal 2023.
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $25.00K, a 8.70% increase from fiscal 2022.
- Moleculin Biotech, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $23.00K, a 0.00% change from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2025-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $8.00K derived: sum of 2 quarters · filed 2026-03-18 | $8.00K 10-K · filed 2026-03-18 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.00K derived: sum of 2 quarters · filed 2026-03-18 | $26.00K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $26.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $25.00K 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $4.00K derived: sum of 2 quarters · filed 2025-03-21 | $25.00K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $25.00K 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $21.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $11.00K derived: sum of 2 quarters · filed 2024-03-22 | $23.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $23.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $12.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $23.00K derived: sum of 2 quarters · filed 2023-03-22 | $23.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $24.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $17.00K 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $17.00K 10-Q · filed 2021-11-10 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $0.00 10-K · filed 2021-03-24 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |